You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AXSM Sale Disclosure
Coleman Mark · SEC Form 4 · Filed Jun 2, 2026
Sale
Calculated transaction value
$1.24M
Coleman Mark Director
AXSM
Axsome Therapeutics
AXSM
Transaction date
Jun 2, 2026
Public filing date
Jun 2, 2026
Filing lag
Filed same day
AXSM daily price context
Close on/before transaction
$222.16
Jun 2, 2026
First close after public filing
$233.49
Jun 3, 2026
30-day return after filing
+4.63%
Through Jul 2, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 5,537 shares @ $223.39
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-254038
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$4.02M
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Axsome Therapeutics, Inc. AXSM Current | Sale | Jun 2, 2026 | $1.24M |
| Axsome Therapeutics, Inc. AXSM | Sale | Jun 1, 2026 | $1.38M |
| Axsome Therapeutics, Inc. AXSM | Sale | May 29, 2026 | $1.4M |